Histone cluster 1 H1e inhibitors belong to a broader category of compounds known as histone inhibitors, specifically targeting the H1e subtype of histone H1, which plays a pivotal role in chromatin remodeling and gene regulation. The H1e subtype is among the linker histones that interact with the nucleosome and the intervening DNA, assisting in the compaction of chromatin structure. Inhibitors targeting this histone subtype aim to modulate the structural configuration of chromatin by affecting the biochemical interactions, post-translational modifications, or the overall stability of the H1e histone within the nucleosome complex. Such modulation ultimately influences the accessibility of transcriptional machinery to specific genomic regions, thereby playing a role in gene expression regulation.
The chemical moieties that make up histone cluster 1 H1e inhibitors are diverse, including small molecules and synthetic compounds, which are meticulously designed to interact with histone H1e or its associated complexes. The molecular mechanisms through which these inhibitors operate vary but commonly involve the alteration of histone H1e binding affinity to DNA or interference with post-translational modifications such as methylation or acetylation. This leads to changes in chromatin structure, either promoting a more relaxed form that is permissive to transcription or a more condensed form that is restrictive. The precise modulation of histone H1e function by these inhibitors underscores their significance in the realm of molecular and cellular biology, expanding our understanding of chromatin dynamics and gene regulation mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
TSA is a histone deacetylase (HDAC) inhibitor. It indirectly affects H1 histones by enhancing acetylation, promoting a more open chromatin structure and facilitating transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid is an HDAC inhibitor that impacts H1 histones by enhancing histone acetylation, promoting transcriptional activity. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Romidepsin is another HDAC inhibitor. It influences the acetylation state of H1 histones, promoting a relaxed chromatin configuration and transcription. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
Belinostat is an HDAC inhibitor. It affects H1 histones indirectly by modifying acetylation levels, affecting chromatin structure and transcription. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat is a potent HDAC inhibitor that can influence H1 histones by modifying their acetylation status, affecting chromatin architecture and gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid, an HDAC inhibitor, alters the acetylation status of H1 histones, influencing chromatin structure and subsequently gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Sodium butyrate is an HDAC inhibitor. It can modify the acetylation levels of H1 histones, impacting chromatin conformation and transcriptional activity. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275 is an HDAC inhibitor that can affect H1 histones by altering acetylation levels, influencing gene expression through changes in chromatin structure. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
Mocetinostat is an HDAC inhibitor that acts on H1 histones by modifying acetylation, affecting chromatin structure and transcriptional regulation. | ||||||
ITF2357 | 732302-99-7 | sc-364513 sc-364513A | 5 mg 50 mg | $340.00 $1950.00 | ||
Givinostat is an HDAC inhibitor that influences the acetylation state of H1 histones, impacting chromatin openness and transcriptional activity. |